{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:22:29Z","timestamp":1785424949063,"version":"3.56.0"},"reference-count":59,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2025,10,23]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Influenza A viruses continuously circulate among avian and swine species, posing a persistent threat to public health. The development of influenza candidate vaccine viruses (CVVs) plays a pivotal role in the global strategy for influenza pandemic preparedness. Safety-testing of CVVs for attenuation in ferrets represents a critical step that takes place prior to making these viruses available to vaccine manufacturers. Development of pathogenicity standards is needed to establish acceptable thresholds of disease so that CVV safety can be assessed without the need for comparison to the parental virus. To assess the capacity of diverse CVVs to cause pathogenesis in mammalian hosts, clinical and virological parameters were compiled from CVV assessments in ferrets conducted using consistent methods over approximately 20 years to identify disease parameters most reflective of attenuation compared to wild-type strains. These analyses revealed an overall reduction in ferret weight loss and fever relative to wild-type controls. Viral titers in nasal washes were reduced with limited spread to tissues beyond the respiratory tract. Regression models further support the significance of clinical signs in distinguishing the virulence of wild-type viruses and CVVs. These findings provide support for the development of standardized parameters for assessing pathogenicity of CVVs and their suitability for manufacturers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>The development and safety testing of candidate vaccine viruses (CVVs) against emerging zoonotic influenza strains prior to sharing with vaccine manufacturers is a critical component of influenza pandemic preparedness. The extensive data set reported here provides critical information that will drastically streamline the safety testing process, thereby enabling more efficient CVV assessments and improving public health in the event of an influenza pandemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/jvi.01023-25","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T13:00:11Z","timestamp":1758114011000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["Identification of clinical and virological correlates associated with influenza A candidate vaccine virus (CVV) attenuation in a ferret model"],"prefix":"10.1128","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1867-1147","authenticated-orcid":false,"given":"Claudia","family":"Pappas","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brock","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-7368","authenticated-orcid":true,"given":"Jessica A.","family":"Belser","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3711-0727","authenticated-orcid":false,"given":"Troy J.","family":"Kieran","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna A.","family":"Pulit-Penaloza","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-1337","authenticated-orcid":true,"given":"Xiangjie","family":"Sun","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-7493","authenticated-orcid":false,"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence M.","family":"Tumpey","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4097-6724","authenticated-orcid":true,"given":"Taronna R.","family":"Maines","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00qzjvm58","id-type":"ROR","asserted-by":"publisher"}],"name":"Influenza Division, Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31274-6"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/82_2014_419"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.100973:100973"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.010"},{"key":"e_1_3_4_6_2","unstructured":"GIP. 2019. Global influenza strategy 2019-2030. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/311184\/9789241515320-eng.pdf?sequence=18"},{"key":"e_1_3_4_7_2","unstructured":"World Health Organisation. 2005. WHO guidance on development of influenza vaccine reference viruses by reverse genetics. Available from: https:\/\/iris.who.int\/handle\/10665\/69051"},{"key":"e_1_3_4_8_2","unstructured":"World Health Organisation. 2019. Annex 3: guidelines for the safe development and production of vaccines to human pandemic influenza viruses and influenza viruses with pandemic potential. Guidelines for the safe development and production of vaccines to human pandemic influenza viruses and influenza viruses with pandemic potential Annex 3 TRS No 1016. https:\/\/www.who.int\/publications\/m\/item\/human-pandemic-influenza-viruses-annex-3-trs-no-1016."},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.007823"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158550"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuz019"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/2515135518821625"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2009.00104.x"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.044"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15892-3"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2017.08.024"},{"key":"e_1_3_4_17_2","unstructured":"World Health Organisation. 2018. Informal consultation on WHO biosafety risk assessment and guidelines for the production and quality control of novel human influenza candidate vaccine viruses and pandemic vaccines. Informal consultation on WHO biosafety risk assessment and guidelines for the production and quality control of novel human influenza candidate vaccine viruses and pandemic vaccines. https:\/\/www.who.int\/publications\/m\/item\/informal-consultation-WHO_flu_meeting_April_2018."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.01.036"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1177238"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2019.08.008"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00095-18"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.01.002"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad359"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00434-23"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.18.11788-11800.2005"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605134103"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2016.12.024"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69535-5"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2809.220879"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01438-15"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01235-07"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12391"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12322"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01740-18"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00451-20"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159625"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(89)90004-9"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.050511"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0042-6822(03)00458-6"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1101\/2022.04.02.486825"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058337"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042343"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44298-024-00074-w"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012460"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.13.64"},{"key":"e_1_3_4_46_2","first-page":"11","article-title":"The three Rs of russell & burch and the testing of biological products","volume":"86","author":"Balls M","year":"1996","unstructured":"Balls M, Straughan DW. 1996. The three Rs of russell & burch and the testing of biological products. Dev Biol Stand 86:11\u201318.","journal-title":"Dev Biol Stand"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01536-22"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1012947"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12698"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"e_1_3_4_51_2","volume-title":"Biosafety in Microbiology and Biomedical Laboratories","author":"U.S. Department of Health and Human Services CfDCaP, and National Institutes of Health","year":"2020","unstructured":"U.S. Department of Health and Human Services CfDCaP, and National Institutes of Health. 2020 Biosafety in Microbiology and Biomedical Laboratories. 6th ed. U.S. Government Printing Office, Washington, DC.","edition":"6"},{"key":"e_1_3_4_52_2","unstructured":"World Health Organisation. 2007. Annex 5: WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v033.i01"},{"key":"e_1_3_4_54_2","unstructured":"Goodrich B Gabry J Ali I Brilleman S. 2024. Rstanarm: bayesian applied regression modeling via stan. R package version 2.32.1"},{"key":"e_1_3_4_55_2","unstructured":"Makowski D Ben-Shachar MS Patil I L\u00fcdecke D. 2020. Automated results reporting as a practical tool to improve reproducibility and methodological best practices adoption. CRAN. Available from: https:\/\/githubcom\/easystats\/report. Retrieved 1 Mar 2023."},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: elegant graphics for data analysis","author":"Wickham H","year":"2009","unstructured":"Wickham H, Sievert C. 2009. ggplot2: elegant graphics for data analysis. Vol. 10. Springer New York."},{"key":"e_1_3_4_58_2","unstructured":"Kassambara A. 2018. ggpubr:'ggplot2'based publication ready plots. R package version:2"},{"key":"e_1_3_4_59_2","unstructured":"Iannone R Cheng J Schloerke B Hughes E Lauer A Seo J. 2022. Gt: Easily create presentation-ready display tables. R package version 07 0 Ed2022"},{"key":"e_1_3_4_60_2","unstructured":"Garnier S Ross N Rudis R Camargo AP Sciaini M Scherer C. 2021. Rvision-colorblind-friendly color maps for R. R package version 06 2"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01023-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01023-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:17:36Z","timestamp":1761225456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.01023-25"}},"subtitle":[],"editor":[{"given":"Paul G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,23]]}},"alternative-id":["10.1128\/jvi.01023-25"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01023-25","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"2025-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01023-25"}}